Media coverage of drug regulatory agencies' safety advisories: A case study of citalopram and denosumab.

ABSTRACT:

Aims

Drug regulators issue safety advisories to warn clinicians and the public about new evidence of harmful effects of medicines. It is unclear how often these messages are covered by the media. Our aim was to analyse the extent of media coverage of two medicines that were subject to safety advisories from 2007 to 2016 in Australia, Canada, the United Kingdom and the United States.

Methods

Two medicines widely used to treat mental health or physical conditions were selected: citalopram and denosumab. Media reports were identified by searching LexisNexis and Factiva. Reports were included if they stated at least one health benefit or harm. A content analysis of the reports was conducted.

Results

In total, 195 media reports on citalopram and 239 on denosumab were inclu

SUBMITTER: Fabbri A 

PROVIDER: S-EPMC7319008 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature